Enter your login e-mail to the account
Search
Search parameters
Search results
- The transferability of pharmacoeconomic studies results between countries
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. MUDr. Róbert Babeľa, PhD.
(1/2009, Pharmacoeconomics )
- Tianeptin abuse
MUDr. Martin Hýža, MUDr. Martina Čechová
(4/2015, Original articles & case reports )
- Early highefficacy mulitple sclerosis treatment: therapeutic success despite safety barriers
MUDr. Dominika Šťastná, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D., doc. MUDr. Dana Horáková, Ph.D.
(6/2023, Case reports ) - Ocrelizumab since the first multiple sclerosis attack – a milestone in reimbursement criteria
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(4/2022, Review articles ) - High efficacy treatment since the first attack – an important step in the treatment of multiple sclerosis?
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(1/2023, Review articles ) - High-efficacy drugs in early stage of multiple sclerosis
MUDr. Veronika Tichá, Ph.D.
(5/2022, Review articles ) - Treatment of multiple sclerosis in Czech Republic – options and reality
MUDr. Michal Dufek
(1/2014, Review articles ) - Ocrelizumab – what we know, what we can improve now, what we can improve in the future
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Buprenorphine as an innovation in the treatment of chronic pain
doc. MUDr. Jitka Fricová, Ph.D.
(1/2024, From the boundary of neurology ) - Biological therapy of migraine: can patients who do not respond to the first anti-CGRP antibody be helped by changing treatment? Case reports from the Headache Center in Thomayer University Hospital, Prague
MUDr. Jolana Marková, FEAN
(5/2023, Case reports ) - Improving gait in patients with multiple sclerosis
Mgr. Klára Novotná, Ph.D., MUDr. Jana Lízrová Preiningerová
(3/2022, From the boundary of neurology )
- Migration and public health in the Slovak Republic
MUDr. Zora Brucháčová, MBA, PhD.
(3/2016, Review articles ) - DOES EUROPEAN „ORPHAN“ MEDICINAL PRODUCTS LEGISLATION HELP TO TREAT CHILDREN SUFFERING FROM RARE DISEASES?
doc. RNDr. Magdaléna Kuželová, CSc.
(5/2007, Review articles )
- The role of palliative medicine in the organizational frame of oncological care in Slovakia
MUDr. Kristina Križanová
(4/2012, Main topic ) - Health technology assessment and value for money in drug policy
PharmDr. Martin Višňanský, MBA, PhD., MSc., Mgr. Radoslav Suchovič
(2/2017, Main topic ) - Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Criteria of the oncology drugs categorisation process on use of the principle „the value for money“ from the point of view of expected benefits
MVDr., Mgr. Peter Mrva, MPH
(2/2017, Main topic ) - Quantification of the impact of cost-effectiveness threshold on cancer drugs reimbursement in Slovakia
RNDr. Mária Pšenková, MPH, Mgr. Marek Psota, PhD., Ing. Martin Suchanský, doc. RNDr. Martina Ondrušová, PhD., MPH
(2/2017, Main topic ) - Publikujeme v zahraničí
(2/2012, Information & comments ) - Cancer Drugs Fund – starting point or final solution to pay for innovative oncology treatment?
MUDr. Pavol Adamkov, Ing. Petra Szilágyiová, Mgr. Tomáš Pastorek
(1/2014, Main topic ) - Optimal treatment sequence in the treatment of locally advanced unresectable and metastatic urothelial carcinoma under current reimbursement mechanisms in Slovakia
MUDr. Jana Gabajová
(3/2024, Review articles ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments )
- Výber abstraktov zo XIV. kongresu slovenských a českých dermatovenerológov s medzinárodnou účasťou, Jasná 2018
redakcia
(3/2018, Abstracts ) - A guide to biological treatment of psoriasis for an outpatient dermatologist
MUDr. Mária Breznická
(2/2021, Review articles )
- Trends in consumption of drugs for respiratory system in the Slovak Republic
Doc. PharmDr. Tomáš Tesař, PhD., MPH, MBA, MSc (HTA), PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD.
(1/2018, Clinical pharmacy )
- Súčasné štandardy chirurgickej liečby slabinových prietrží. Druhá časť
MUDr. Martin Huťan, PhD., MUDr. Michaela Huťanová, MUDr. Patrik Koudelka, PhD., MUDr. Juraj Kutarňa, PhD., doc. MUDr. Augustín Prochotský, CSc., MUDr. Jaroslav Sekáč, PhD., Gerhard Loncsar, dr.med.
(2/2018, Review articles ) - Súčasné štandardy chirurgickej liečby slabinových prietrží. Prvá časť
MUDr. Martin Huťan, PhD., MUDr. Jaroslav Sekáč, PhD., MUDr. Michaela Huťanová, MUDr. Patrik Koudelka, PhD., MUDr. Juraj Kutarňa, PhD., doc. MUDr. Augustín Prochotský, CSc., Gerhard Loncsar, dr.med.
(1/2018, Review articles )
- Intensive care in the district hospital and its reimbursement in the DRG system
MUDr. Mária Voleková, MUDr. Garryk Slobodianiuk
(2/2018, Original articles )